KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Invested Capital (2016 - 2025)

Merck (MRK) has disclosed Invested Capital for 17 consecutive years, with $2.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital fell 94.72% to $2.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 billion, a 94.72% decrease, with the full-year FY2025 number at $2.6 billion, down 94.72% from a year prior.
  • Invested Capital was $2.6 billion for Q4 2025 at Merck, down from $53.3 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $53.3 billion in Q3 2025 to a low of $2.6 billion in Q4 2025.
  • A 5-year average of $42.4 billion and a median of $44.9 billion in 2022 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: grew 29.05% in 2022, then crashed 94.72% in 2025.
  • Merck's Invested Capital stood at $40.7 billion in 2021, then grew by 18.04% to $48.0 billion in 2022, then dropped by 18.74% to $39.0 billion in 2023, then rose by 25.67% to $49.0 billion in 2024, then plummeted by 94.72% to $2.6 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Invested Capital are $2.6 billion (Q4 2025), $53.3 billion (Q3 2025), and $50.5 billion (Q2 2025).